Status: Recruiting
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION
This trial will study the safety and efficacy of intravenous and sub-tenon delivery of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of non-arteritic ischemic optic neuropathy
Participants needed: 20
Trial details
Phase: Phase 1Biological sex: AllType: InterventionalSponsor: The Foundation for Orthopaedics and Regenerative MedicineUpdated: Apr 17, 2025Locations: 2
Eligibility criteria
Diagnosis of NAION (non-arteritic ischemic optic neuropathy) [+1]
Active infection [+9]